Maintenance Therapy in Acute Myeloid Leukemia: Current Perspectives and Future Directions.

Curr Oncol · 2026 · PMC13298856 · PMID 42346269

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

15.1 months; HR 0.78; 95% CI, 0.62–0.98; p = 0.032) and showed a trend towards improved OS when censoring for allo-HSCT (HR 0.75; 95% CI, 0.56–1.01).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.